Veradermics MANE
NYSE MANE
$138.38 +1.98 (+1.45%)
At close: Oct 22, 2026 · 4:00 PM EDT

Veradermics (MANE) Free Cash Flow (2025 - 2026)

Updated

Veradermics (MANE) posted Free Cash Flow of -$14.52 million for Q2 2026, compared with -$15.68 million a year earlier.

Analysis

Veradermics (MANE) Free Cash Flow (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Free Cash Flow at Veradermics was -$64.74 million; for FY2025, it was -$71.63 million.

  • In prior years, Veradermics' Free Cash Flow was -$23.7 million in FY2024.
  • The Q2 2026 figure stands as the highest quarterly Free Cash Flow since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 7.76 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 6.36 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 3.11 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 4.48 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 5.56 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 1.01 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 3.49 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 3.43 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 302.00 Mn
10 Veradermics 5.78 Bn 4.38 Bn - -14.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -14.52 Mn
Mar 31, 2026 -21.20 Mn
Jun 30, 2025 -15.68 Mn
Mar 31, 2025 -13.34 Mn
API Access

Veradermics Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=MANE&period=max&api_key=YOUR_API_KEY